Alcon Inc (ALC)
81.09
-0.19
(-0.23%)
USD |
NYSE |
Apr 15, 16:00
79.84
-1.25
(-1.54%)
Pre-Market: 07:35
Alcon Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 1.217B |
| September 30, 2022 | 1.259B |
| June 30, 2022 | 1.273B |
| March 31, 2022 | 1.255B |
| December 31, 2021 | 1.345B |
| September 30, 2021 | 1.397B |
| June 30, 2021 | 1.307B |
| Date | Value |
|---|---|
| March 31, 2021 | 949.00M |
| December 31, 2020 | 823.00M |
| September 30, 2020 | 730.00M |
| June 30, 2020 | 677.00M |
| March 31, 2020 | 920.00M |
| December 31, 2019 | 920.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
677.00M
Minimum
Jun 2020
1.397B
Maximum
Sep 2021
1.082B
Average
1.217B
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| AC Immune SA | -67.27M |
| CRISPR Therapeutics AG | -260.38M |
| Addex Therapeutics Ltd | -11.74M |
| NLS Pharmaceutics Ltd | -13.51M |
| Molecular Partners AG | -65.71M |